Analysis of HE4(WFDC2) expression as a new candidate molecular marker of gastric cancer.

Analysis of HE4(WFDC2) expression as a new candidate molecular marker of gastric cancer. - Analysis of gene expressions of new candidates for gastric cancer molecular markers.

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000003899

Enrollment

300

Registered

2010-07-09

Start date

2010-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Gastric cancer patients, who have been notified about the diagnosis, and have planned for admission for surgical resection of gastric cancer.

Exclusion criteria

Exclusion criteria: Not applied

Design outcomes

Primary

Measure	Time frame
HE4(WFDC2) mRNA expression level and protein transcripts, OS(Overall Survival), progression and pathological / biological characteristics of the gastric cancers.	—

Secondary

Measure	Time frame
HE4(WFDC2) mRNA expression level and protein transcripts, before surgical resection of gastric cancer, after surgical resection, during adjuvant chemotherapy, and after chemotherapy.	—

Countries

Japan

Contacts

Public ContactKoji Nozaki MD, PhD

The University of Tokyo Hospital Clinical Research Support Center

knozaki-tky@umin.ac.jp03-3815-5411

Outcome results